Zimmer Biomet (ZBH) PT Raised to $185 at Needham & Company Highlighted as Top Healtcare Pick for 2021
Tweet Send to a Friend
Needham & Company analyst Mike Matson raised the price target on Zimmer Biomet (NYSE: ZBH) to $185.00 (from $168.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
